Overview

Ivermectin and Human Immunity

Status:
Completed
Trial end date:
2018-11-30
Target enrollment:
Participant gender:
Summary
We hypothesize that ivermectin, a drug used to treat parasitic worm infections, interacts with the human innate immune system and that this contributes to its anti-parasitic effects. Participants will donate blood before and after being administered the normal human dose of the drug. We will compare the cell types present in the blood and the chemicals known to influence the human immune system before and after the drug is given, as well as measuring any changes in gene expression in white blood cells 4 and 24hrs after the drug is taken.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Georgia
Treatments:
Ivermectin